The 3M share increase provides headroom for future equity compensation but does not represent immediate dilution. Monitor future 10-Q filings for actual share issuance under the plan. No near-term catalyst from this filing.
ELUT drugs
ELUT drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Jun 17 $0.9914entry
- T+1 · 5mo ago +6.92%α +6.14% · $1.06
- T+5 · 5mo ago −1.04%α +0.00% · $0.9811
- T+20 · 4mo ago −4.18%α −5.49% · $0.9500
- T+60 · 2mo ago −18.30%α −21.45% · $0.8100
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Elutia Inc. filed an 8-K reporting the results of its 2026 Annual Meeting of Stockholders, where shareholders approved an amendment to the 2020 Incentive Award Plan, increasing authorized shares by 3,000,000. All director nominees were elected, and advisory say-on-pay was approved with an annual frequency recommendation. This is a routine governance filing with no material financial impact.
Key Facts
- Shareholders approved the First Amendment to the 2020 Incentive Award Plan, increasing authorized shares by 3,000,000 shares of Class A common stock.
- Annual meeting had 34,041,545 shares present (77.0% of outstanding) as of April 17, 2026 record date.
- David Colpman and Kevin Rakin were elected as Class III directors.
- PricewaterhouseCoopers LLP ratified as independent auditor for FY2026.
- Advisory say-on-pay approved with 25,617,864 votes for; annual frequency recommended.
Financial Impact
Potential dilution from up to 3,000,000 additional shares authorized for equity awards; no immediate financial impact.
Risk Factors
- Potential dilution from future equity awards under the expanded plan.
- No material change to business fundamentals or financial outlook.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001104659-26-074660 |
| Document: 0001104659-26-074660-index-headers.html | 0001104659-26-074660 |
| Document: 0001104659-26-074660-index.html | 0001104659-26-074660 |
| Document: 0001104659-26-074660.txt | 0001104659-26-074660 |
Track record
7 reports on ELUT
Filters
- Nov 5, 202611d ago Press Release Neutral 4/10 No price data
- Nov 5, 202611d ago 8-K Neutral 5/10 Entry $0.8374 Now $0.8230 −1.72% settles Dec 7
- Oct 22, 202625d ago Press Release Neutral 1/10 Entry $0.8615 Now $0.8230 −4.47% settles Nov 20
- Jul 31, 202615w ago Press Release Neutral 1/10 Entry $0.8568 to $0.8800 Now $0.8230 −3.94% ▲ +2.71% −0.28% vs SPY
- Jun 16, 202621w ago 8-K Neutral 3/10 Viewing Entry $0.9914 to $0.9500 Now $0.8230 −16.99% ▼ −4.18% −5.49% vs SPY
- May 14, 202626w ago 8-K Neutral 5/10 Entry $1.03 to $0.9690 Now $0.8230 −20.10% ▼ −5.92% −8.04% vs SPY
- Mar 11, 202635w ago 8-K Mixed 7/10 Entry $1.15 to $1.13 Now $0.8230 −28.43% ▼ −1.74% −3.71% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers